Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection  by Liu, Longding et al.
Virology 412 (2011) 91–100
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roNeonatal rhesus monkey is a potential animal model for studying pathogenesis
of EV71 infection
Longding Liu a,1, Hongling Zhao a,1, Ying Zhang a, Jingjing Wang a, Yanchun Che a, Chenghong Dong a,
Xuemei Zhang a, Ruixiong Na a, Haijing Shi a, Li Jiang a, Lichun Wang a, Zhongping Xie a, Pingfang Cui a,
Xiangling Xiong b, Yun Liao a, Shudong Zhao a, Jiahong Gao a, Donghong Tang a, Qihan Li a,⁎
a Institute of Medical Biology, Chinese Academy of Medicine Science, Kunming 650118, PR China
b Kunming Medical University, Kunming 650032, PR China⁎ Corresponding author. Institute of Medical Biology,
Science and Peking Union Medical College, 379 Jiaolin
China, 650118. Fax: +86 871 8334483.
E-mail address: imbcams.lq@gmail.com (Q. Li).
1 Longding Liu and Hongling Zhao contributed equall
0042-6822/$ – see front matter © 2011 Elsevier Inc. Al
doi:10.1016/j.virol.2010.12.058a b s t r a c ta r t i c l e i n f oArticle history:
Received 26 October 2010
Returned to author for revision
30 November 2010
Accepted 30 December 2010
Available online 22 January 2011
Keywords:
Enterovirus 71 (EV71)
Hand–foot–mouth disease (HFMD)
Neonatal rhesus monkey
Animal model
PathogenesisData from limited autopsies of human patients demonstrate that pathological changes in EV71-infected fatal
cases are principally characterized by clear inﬂammatory lesions in different parts of the CNS; nearly identical
changes were found in murine, cynomolgus and rhesus monkey studies which provide evidence of using
animal models to investigate the mechanisms of EV71 pathogenesis. Our work uses neonatal rhesus monkeys
to investigate a possible model of EV71 pathogenesis and concludes that this model could be applied to
provide objective indicators which include clinical manifestations, virus dynamic distribution and
pathological changes for observation and evaluation in interpreting the complete process of EV71 infection.
This induced systemic infection and other collected indicators in neonatal monkeys could be repeated; the
transmission appears to involve infecting new monkeys by contact with feces of infected animals. All data
presented suggest that the neonatal rhesus monkey model could shed light on EV71 infection process and
pathogenesis.Chinese Academy of Medicine
g Road, Kunming, Yunnan, PR
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Enterovirus 71 (EV71) is commonly recognized as themain human
pathogen of hand–foot–mouth disease (HFMD), occasionally causing
severe fatality (Ooi et al., 2007). Several severe epidemic outbreaks
involving large groups within populations have occurred globally,
speciﬁcally in Asia-Paciﬁc regions, since the 1990s (CDC, 1998; Chan
et al., 2000; Shimizu et al., 1999). Notably, though mild clinical
manifestations of HFMD are characterized as papules, vesicles or
petechiae of hand, foot and mouth in millions of patients (Ho et al.,
1999; Liu et al., 2000); a considerable number of people, speciﬁcally
infants and young children, infected by EV71 develop severe disease
(Ho et al., 1999; McMinn, 2002). In the outbreaks of HFMD involving
hundreds of thousands of cases in Taiwan from 1999 to 2001, several
hundreds of fatal cases with high mortality in young children were
reported (Ho et al., 1999; Lin et al., 2003b). From 2008 to 2010, an
average of several hundreds of deaths caused by EV71 infection in
young children are reported each year in the Chinese Mainland (Ding
et al., 2009; Xu et al., 2010; Yang et al., 2009). Most of the fatal casescaused by EV71 infection are typically associated with neural diseases
and complications of the central nervous system (CNS) and
subsequently lead to pulmonary edema and function collapse due to
rapid development and progress of disease (Lin et al., 2006), which
makes clinical treatment of such acute viral-induced diseases
challenging (Lin et al., 2006). Though mechanisms of neuropathogen-
esis in enteroviral infections, poliovirus infection for example, have
been extensively described in many studies (Couderc et al., 1989;
Whitton et al., 2005), the potential pathogenesis of EV71 infection
remains unknown. Results from limited autopsies demonstrate that
pathological changes in EV71-infected fatal cases are principally
characterized by clear inﬂammatory lesions in the oblongata,
hypothalamus, spinal cord and other parts of the CNS in a pattern of
neural cell necrosis, degeneration, local inﬂammatory cell inﬁltration,
perivascular cufﬁng formation and so on (Wong et al., 2008). In
contrast, the typical clinical symptoms in non-neural organs exhibit
the development of pulmonary edema (Hsueh et al., 2000), which can
frequently lead to deaths in young children. It is generally believed
that the study of the pathogenesis of EV71 infection in clinical patients
could be extremely difﬁcult compared to studies in different animal
models that have already documented signiﬁcant advances in further
characterizing the pathogenesis of EV71 infection (Nagata et al., 2002;
Ong et al., 2008). A study in a murine model indicates that the
challenge of adapted mutants such as the MAVS strain (Wang et al.,
2004) can lead directly to ﬂaccid paralysis or death of mice and
92 L. Liu et al. / Virology 412 (2011) 91–100corresponding pathological changes in CNS (Ong et al., 2008;Wang et
al., 2004). Likewise, challenge with a temperature resistant mutant (tr
strain) in cynomolgus monkeys can induce symptoms of neurological
disorders, such as ﬂaccid paralysis and ataxia, as well as
corresponding pathological changes in CNS (Hashimoto and Hagi-
wara, 1983). These data provide evidence that using animal models in
the study of the development of EV71 vaccines and anti-viral drugs
could be fruitful. However, as a result of the limits of themodiﬁed viral
strains, when compared to natural human viral infection, the potential
pathogenesis process of EV71 infection in its natural host cannot be
sufﬁciently deﬁned by current data.
We have previously studied the possibility of using rhesus monkeys
as an animal model for EV71 infection by an EV71 strain isolated from a
patient with HFMD through different EV71-infected routes of the
intracerebral, intravenous, respiratory and intestinal systems. As shown
in the dynamic and comprehensive pathogenic analysis and histopath-
ological examination on adult rhesus monkeys, the basic pathogenesis
process of EV71 infection includes exhibition of regular viremia, speciﬁc
virus dynamic proﬁle and subsequentmajor neuropathological changes
in the CNS (Zhang et al., Submission); the preference of EV71 to
respiratory infection has been sufﬁciently demonstrated, despite a lack
of typical clinical manifestations of HFMD like papules, vesicles or
petechiae and even ﬂaccid paralysis in the severe cases. On the basis of
these data and investigations of EV71-infected humans, it is generally
believed that animals, particularly non-humanprimates, could beusefulFig. 1. Clinical manifestations of neonatal rhesus monkey infected by EV71 via respiratory ro
used as uninfected negative controls. (a) Vesicular lesions in the mouth and foot of newbor
EV71. Body temperatures of infectedmonkeys weremeasured by anus rout twice each day po
and referring Li, 2005) ranging from 38 to 39 °C were showed as dot line. (c) The blood cell
containing lymphocytes, monocytes, neutrophils, eosinophilic leucocytes and basophilic le
monkeys and referring Sibley, 1974) were showed as dot line. Blood samples were collected
of certain inﬂammatory markers.in mimicking the EV71 infectious process. Studying EV71 infection in
these animal models would provide more data about the pathogenesis
of EV71 infection in humans. In the light of this, our work is further
focused on the study of the EV71 infectious process in neonatal rhesus
monkeys; we analyzed the virus dynamic proﬁle, corresponding
pathological changes in some organs and the resulting clinical
manifestations. Additionally, we succeeded in replicating the infectious
process in new rhesus monkeys using feces of EV71-infected neonatal
monkeys. These ﬁndings appear to suggest that neonatal rhesus
monkeys could potentially be used as an effective animal model for
EV71 infection in the development of new drugs and vaccines, which
might provide new insights into understanding EV71 infection and its
associated pathogenesis.
Results
Clinical manifestations in EV71-infected neonatal rhesus monkeys
In our previous studies of EV71-infected adult monkeys, neither
typical neurological symptoms in EV71-infected animals nor the
papules or vesicles on limbs and mouths found in EV71-infected
humans were observed. The only clinical sign was of body
temperature elevation (Supplemental Table 1) (Zhang et al., Submis-
sion). In the current study, the typical ﬂaccid paralysis was not noticed
in infected neonates, but slight muscle tension decreased from days 7ute. 8 monkeys were challenged with EV71 (104.5 CCID50/monkey) and 2 monkeys were
n rhesus monkey. (b) Monitoring on body temperatures of rhesus monkeys infected by
st-infection. The normal body temperatures (data collected from two negativemonkeys
analysis using FCM and number statistic measure of rhesus monkeys infected by EV71,
ukocytes. The percentages of normal cells ranging (data collected from two negative
in whole course of EV71 infection (1–14 days post-infection) for detecting the presence
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mouths (Fig. 1a) from days 3 to 8 p.i.; body temperatures increased to
some extent from days 4 to 8 p.i. (Fig. 1b) and blood cell examination
revealed an increased number of mononuclear cells in some monkeys
(Fig. 1c). These observations suggested that, when compared with
usual clinical symptoms in infected adult monkeys (Supplemental
Table 1), the papules or vesicles manifested on limbs and mouths in
neonates might result from the difference in age at infection. Such
clinical signs are not identiﬁed in animal models of cynomolgus
monkeys (Nagata et al., 2004) but are quite similar to those in human
infants and young children and are conﬁrmed by histopathological
examination and pathogenic analysis (see later description). Inter-
estingly, and for unknown reasons, the typical neurological complica-
tions including ﬂaccid paralysis were not observed. Although the
ataxia, paralysis and other typical features have been reported by
Nagata in cynomolgus monkeys (Nagata et al., 2004), there are only a
few clinical reports of ﬂaccid paralysis being a main characterization
in human cases of HFMD in recent outbreaks (Kung et al., 2007)
regardless of some paralysis cases found in previous epidemics
induced by B or C1 genotype virus in Europe (Kapusinszky et al., 2010;
Ortner et al., 2009). However, the clinical features displayed in
neonatal monkeys, such as papules or vesicles, fever, and inﬂamma-
tory responses indicated in blood cell analysis, as well as clinical
manifestations in EV71-infected humans (Li et al., 2002) lead to the
conclusion that there are signiﬁcant similarities between clinical
featuresmanifesting in EV71-infected neonatal monkeys and humans.Fig. 2. Dynamic distribution of EV71 in infected neonatal rhesus monkey through respirator
were used as uninfected negative controls. (a) Viral RNA was extracted from blood specime
described in manufacturer's protocol. Blood specimens were collected in whole course of
infected rhesus monkeys. Throat swabs and stool specimens were collected in the whole cou
of infected rhesus monkeys (axillary lymph node, mesenteric lymph node, inguinal lymph n
organs and tissues of infected rhesus monkeys (vascular, kidney, lung, esophagus, trachea,
muscle, lower arm muscle, thigh muscle, calf muscle ectopectoralis and vesicular). Tissue
infection. Viral copies were quantiﬁed according to vitro-synthesized RNA by spectropho
determined by the equation [(μg of RNA/μl)/(molecular weight)]×Avogadro's number=vir
the procedure as described in materials and methods. Values are the mean for 2 samples aDynamic proﬁle of virus in tissues of non-neural systems of
EV71-infected neonatal monkeys
It has been previously documented that enteroviruses, in partic-
ular poliovirus, are present in organs of the lymphatic system of
humans at early stages of infection (Ouzilou et al., 2002). Additionally,
as revealed in studies of EV71 infection in murine and cynomolgus
monkey animal models, virus has been frequently found in organs of
many non-neural systems such as blood, heart, lung, spleen and
muscles (Arita et al., 2007; Chen et al., 2004), which has been shown
in our previous work performed on adult rhesus monkeys (Zhang et
al., Submission). In this study of EV71 infection in neonatal rhesus
monkeys, we analyzed viral load proﬁles of tissues and organs with
potential involvement in an EV71 infection. The results indicated that
viremia of neonatal monkeys developed during the period from day 5
to day 8 p.i. were detected by qRT-PCR detection (Fig. 2a) and were
subsequently conﬁrmed by virus titration in tissue culture (Supple-
mental Fig. 1a). The peak time point of this viremia occurred at the
same for viral secretion in the pharynx of neonates (Fig. 2b and
Supplemental Fig. 1b). Virus was detected in feces from viremia
development until day 14 p.i., when monkeys were sacriﬁced (Fig. 2b
and Supplemental Fig. 1b). This appears to imply that viral replication
in corresponding tissues of monkeys is triggered at the time of viremia
manifestation. As indicated in the analysis of EV71 infection in
lymphatic system, viral loads reached the highest level (Fig. 2c) from
days 4 to 7 p.i., particularly in some speciﬁc lymph nodes like they route. 8 monkeys were challenged with EV71 (104.5 CCID50/monkey) and 2 monkeys
ns and measured by Taqman based real-time qPCR assay, according to the procedure as
EV71 infection (1–14 days post-infection). (b) Viral load in throat swabs and feces of
rse of EV71 infection (1–14 days post-infection). (c) Viral titration in lymphatic system
ode, hilar lymph node and submandibular lymph node). (d) Viral titration in the major
bronchus, ileum, brown adipose (beside trachea), axillary brown adipose, upper arm
specimens were collected from organs of these systems on days 4, 7, 10 and 14 post-
tometry quantiﬁcation, and the quantity was expressed as a relative copy number,
al copy number/μl. Viral titration was measured by a microtitration assay, according to
t each time point.
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load levels tended to be negative until day 14 p.i. (Fig. 2c). In addition
to an increase in viral load levels in the lymph nodes, high viral load
levels were detected in main organs, especially in some speciﬁc
tissues of non-neural systems including: trachea, blood vessels, limb
muscles, brown adipose and kidney (Fig. 2d). The highest viral-load
level, 107 CCID50/100 mg, was found in brown adipose tissue of
axillary fossa and extra-trachea tissue. The electron microscopy
analysis of brown adipose tissue showed an arrangement of viral
particles in lines within the cells (Supplemental Fig. 2). A viral load
level of 106 CCID50/100 mg was found in the trachea and blood
vessels, 103–104 CCID50/100 mg in skeletal muscle, (Fig. 2d). As
compared to previous results in adult monkeys (Supplemental
Table 1) (Zhang et al., Submission), these ﬁndings suggest that peak
viral load levels developed between days 4 and 7 p.i., in the organs and
tissues which might eventually be the preferred target organs for
infection, characterize EV71 infection in neonatal monkeys. Addition-
ally, viral detection performed on papules or vesicles taken from
mouths and limbs from days 5 to 8 p.i. further supported the growths'
association with EV71 infection (Fig. 2d).
Viral distribution in the neural system of EV71-infected neonatal
monkeys
The main target organs of EV71 infection in humans and other
associated animal models has been identiﬁed to involve the central
nervous system (CNS) (Lin et al., 2003a; Nagata et al., 2004; Ong et al.,
2008; Wong et al., 2008) with infection characterized by clear
neuropathological changes in a pattern of remarkable viral load
distribution in the CNS (Ong et al., 2008; Wong et al., 2008). Several
studies in murine models have suggested that EV71 is able to enter
the CNS by transmission via peripheral nerves (PNS) using an active
retrograde axonal transport route (Chen et al., 2007). In this work,
general viral load distributions in the CNS and PNS were analyzed
dynamically and some interesting ﬁndings were observed. The total
distribution of viral loads tended to increase from day 7 p.i., peaked on
day 10 p.i. followed by gradual decline (Fig. 3a), during which higher
titers were distributed speciﬁcally in the medulla oblongata and
thalamus. This distribution correlates with the observation of peak
viral loads occurring in muscles, brown adipose and trachea organs on
day 7 p.i. Additionally, as shown in viral load detection in trigeminal,Fig. 3. Dynamic viral distribution in CNS and peripheral nerves of infected neonatal rhesus m
(cerebra, cerebellum, medulla oblongata, pons and myelon). (b) Viral titration in periphe
brachial plexus nerve, sciatic nerve and trigeminal nerve). Viral titration was measured by a
Tissue specimens were collected from organs of these systems on days 4, 7, 10 and 14 postbrachial plexus, intercostal and sciatic nerves on 7 days p.i., peak viral
loads were noticed in brachial plexus, intercostal nerves and followed
by subsequent decline (Fig. 3b), which again correlates with brachial
plexus and intercostal nerves that are directly linked to the PNS. This
kind of potential time correlation is sufﬁcient to support the
hypothesis of EV71 transmission to CNS via peripheral nerves by
using an active retrograde axonal transport route. Another marked
ﬁnding is that EV71wasmainly detected in brachial plexus and in part
within intercostal nerves in the PNS where higher viral loads were
detected from days 4 to 7 p.i. Furthermore, these nerves are known to
directly link to control body parts, including the neck, thorax and
limbs, where tissues of axillary brown adipose and lymph nodes,
upper armmuscle and pectoral muscle are found with the presence of
high viral loads, which allows for an implication of correlated
pathogenic process between viral infection routes and the infected
CNS.
Features of pathological changes in EV71-infected neonatal monkeys
In our previous study of EV71 infection of adult rhesus monkeys,
pathological changes were found in various organs of the animals,
among which the most serious and severely infected ones were
determined to be the wide range of CNS and respiratory system
organs such as the trachea (Supplemental Table 1) (Zhang et al.,
Submission). This ﬁnding is consistent with other reports on
neuropathological impairment of the CNS induced by EV71 infection
in other animals (Arita et al., 2007; Chen et al., 2004; Ong et al., 2008).
However, no pathological changes were documented in the respira-
tory systems of the animals. Whether the resistance of this tissue to
change being caused by a failure in inoculation via respiratory route or
other differences of biological properties of virus-adapted mutants
remains unclear. In this study of EV71 infection in neonatal monkeys,
pathological responses to EV71 infection were found in organs of the
respiratory system such as the trachea and lungs, manifesting as
epithelial cell damage and inﬂammatory cell inﬁltration (Fig. 4a); in
contrast, pathological changes were not noticed in other main organs
of the animals. Interestingly, marked inﬂammatory cell inﬁltration
was noted in brown adipose and skeletal muscle tissue where viral
load levels were very high (Fig. 4b). It is well known that brown
adipose is far tissue speciﬁc to human infants and primate neonates
and documented to be infected by poliovirus (Bodian, 1955;onkey through respiratory route. (a) Viral titration in CNS of infected rhesus monkeys
ral nerves of infected rhesus monkeys (intercostals nerve 2, intercostals nerve 5–12,
microtitration assay, according to the procedure as described in Materials and methods.
-infection. Values are the mean for 2 samples at each time point.
Fig. 4. Pathological changes in various tissues of neonatal rhesus monkey infected by EV71 via respiratory. (a) The typical features of pathological changes in respiratory apparatus
(lung and trachea) of EV71 infected rhesus monkeys. Inﬁltration of inﬂammatory cells (black arrow), perivascular cufﬁng (white arrow), edema (blue arrow) and hemorrhage
(green arrow). Images are shown at 200×magniﬁcation. Bar, 30 μm. (b) The typical features of pathological changes inmuscles and brown adipose of EV71 infected rhesus monkeys.
Inﬁltration of inﬂammatory cells (black arrow), perivascular cufﬁng (white arrow), edema (blue arrow), hemorrhage (green arrow), destruction of cell structure (yellow CSD) in
muscles (100× magniﬁcation. Bar, 60 μm.), brown adipose tissues and vesicles (yellow MFI regions— “muscle ﬁber injury”) (200× magniﬁcation. Bar, 30 μm.) were showed. (c) The
typical features of pathological changes in CNS (cerebra, medulla oblongata, thalamus, midbrain, cerebellum and myelon) of EV71 infected rhesus monkeys. These images show
inﬁltration of inﬂammatory cells (black arrow), perivascular cufﬁng (white arrow) and neuron retrogression (yellow arrow and NL regions— “neuronal lesions”). Images are shown
at 200× magniﬁcation. Bar, 30 μm. Samples were collected on day 10 post-infection. The histopathological examinations were performed on 4-μm sections of parafﬁn-embedded
tissue or organ stained with H&E according to the protocol.
95L. Liu et al. / Virology 412 (2011) 91–100Shwartzman et al., 1955). The high viral loads detected in brown
adipose correlate with the presence of remarkable inﬂammatory
changes (Fig. 2d). Additionally, as shown in histopathological
examinations of papules or vesicles on mouths and limbs of EV71-
infected monkeys (Fig. 4b), pathological changes associated with
epithelial necrosis of subcutaneous small blood vessels and marked
inﬂammatory cell inﬁltration in tissue structures were observed,Table 1
Neuropathological evaluation in CNS of newborn rhesus monkeys infected via respiratory r
Infection
rout
Dose Monkey
ID
Neuropathological symptomsa (days post infection)
Brain
Cerebra Thalamus Midbrain
4 7 10 14 4 7 10 14 4 7 10
Respiratory 104.5 5410 1 2 1
5411 3 2 1
5412 3 4 2
5413 2 2
5414 2 1 1
5415 2 1 3
5416 2 3 2
5417 2 1
a CNS lesions were scored according to the evaluation of extent of pathological change i
damage; 3, cellular inﬁltration with extensive neural damage; and 4, massive neural damagimplying that eruption of papules or vesicles in skin results from an
inﬂammatory reaction of endothelial cells in subcutaneous small
blood vessels in response to virus infection. However, the reason for
their occurrence speciﬁcally on limbs requires further study. Again,
the histopathological examination on the CNS revealed neuropatho-
logical lesions in the medulla oblongata, thalamus and gray matter of
the spinal cord, which might contribute to degeneration of neuraloute.
Spinal cord
Medulla
oblongata
Cervical Thorax Lumbar
14 4 7 10 14 4 7 10 14 4 7 10 14 4 7 10 14
2 1 1 1
3 1 1 2
4 2 1 0
1 3 1 1 0
3 2 1 1
2 2 2 1
3 3 2 2
1 1 1 0 1
n CNS: 0, no lesion; 1, cellular inﬁltration; 2, cellular inﬁltration with minimal neural
e with or without cellular inﬁltration.
Table 2a
Clinical manifestations in EV71 respiratory infected new neonatal rhesus monkeys.
Pattern Monkey
ID
Clinical manifestations
Vesicular lesionsa Body temperature (°C) (days post infection)
Mouth Hand Foot 1 3 5 7 9 11 13
Infected new neonatal 5420 Y Y Y 38.5 38.1 39.2 ↑ 39.8 ↑ 40.5 ↑ 39.3↑ 38.7
5421 Y Y N 37.7 38.2 39.5 ↑ 40.3 ↑ 39.9 ↑ 39.0 38.9
↑: The temperature was upper than normal body temperatures ranging from 38 to 39 °C.
a Note: Y: yes or had; N: no or not had.
96 L. Liu et al. / Virology 412 (2011) 91–100cells, perivascular inﬁltration and inﬂammatory cell aggregation etc.
(Fig. 4c). All pathological examinations indicated that the most severe
pathological changes were induced in a broad range of CNS tissues on
day 10 p.i. (Table 1). Concomitantly, all pathological changes observed
in all organs and tissues corresponded to viral antigen expression in
associated tissues (Supplemental Fig. 3).
Infection of other individual neonates by feces of EV71-infected neonatal
monkeys
Based on our previous studies in adult and neonatal rhesus
monkeys (Supplemental Table 1), the respiratory tract is suggested as
the potential main route for EV71 natural infection due to the high
viremia in respiratory tissue during EV71 infection. Epidemiological
studies in humans have further implicated the respiratory tract as a
main route of EV71 transmission in human populations (Han et al.,
2010). To determine the feasibility of using neonatal monkeys as an
animal model for EV71 infection, 100 mg of feces taken from EV71-
infected neonatal monkeys on day 10 p.i. were put in 5 ml PBS for
sterilization and ﬁltration. 500 μl of this solution was sprayed into the
nasal passages of each of 4 neonates and the newly-infected monkeys
were monitored for the aforementioned clinical signs and viral
viremia development until day 14 p.i. when two of the monkeys
were sacriﬁced for overall pathological and pathogenic examinations.
The other two were reared for fecal examinations until day 30 p.i.,
during which time the associated neonates' breast-feeding female
monkey were examined for viral loads in feces. Similar clinical
manifestations, such as papules or vesicles and body temperature
increasing, were exhibited (Table 2a), viremia developed between
days 5 and 8 p.i. (Table 2b), and the virus was detected in the pharynx
and feces (Table 2b). The pathological changes were observed in a
wide range of CNS and respiratory tract tissues of neonates sacriﬁced
on day 14 p.i. (Table 2c) with the same variety and severity as those
characterized in the ﬁrst group of neonates from the same time point.
The biological events of infected neonatal monkeys, which are
progress to development of complete pathological changes and
advancement to infection of new individual neonate by fecal
respiration, followed by induction of similar clinical manifestations
in new individuals, are likely to support the signiﬁcance of using
neonatal rhesus monkeys as an animal model for EV71 infection.Table 2b
Dynamic distribution of EV71 in infected new neonatal rhesus monkeys through respirator
Pattern Monkey
ID
Dynamic
distributiona
Days post infection
1 2 3 4 5 6
Infected new neonatal 5420 Viremia − − − + ++ ++
Throat swab − − − + ++ ++
Feces − − − ± + ++
5421 Viremia − − − ± + ++
Throat swab − − − − + ++
Feces − − − − + ++
−: copies≤100; ±: copies≤101; +: copies≤102; ++: copies≤103; +++: copies≤104; +
a Note: Measured viruses load by Taqman based real-time qPCR assay, according to the pDiscussion
Many researchers have described in detail the pathogenesis of
enteroviruses, particularly poliovirus, Coxsackie A and B and hepatitis
A viruses in humans (Asher et al., 1995; Mena et al., 2000; Racaniello,
2006), the study of which will beneﬁt greatly from the development
of animal models in non-primates and mice for enterovirus infection
(Chen et al., 2004). The precedent for animal models in studying
enterovirus has been clearly demonstrated during the work on
poliovirus and development of the polio vaccine (Dragunsky et al.,
1996; Horie et al., 1994). With regard to the EV71 infectious disease
and its unknown pathogenesis, development of animal models using
primates with a close genetic relationship to humanswill facilitate the
study of EV71 pathogenesis. Our previous work has characterized the
EV71 infectious process and its associated pathological changes in
adult rhesus monkeys (Supplemental Table 1) (Zhang et al.,
Submission). The clinical manifestations, variety of viral load
distributions and corresponding pathological features are discussed
in the current study, further demonstrating the feasibility of using
neonatal rhesus monkeys as an animal model for EV71 infection.
The clinical features in EV71-infected neonatal monkeys, in
addition to general signs of fever, were pathological changes
characterized by typical vesicles or papules on limbs and mouth
(Fig. 1) and were conﬁrmed to be similar to that in human patients
with HFMD (Ho et al., 1999). Such changes are described for the ﬁrst
time in animal models for EV71 infection. The pathogenic analysis
showed a viral load of over 103 CCID50/100 mg in tissues of vesicles or
papules (Fig. 2). The histopathological examination of these tissues
clearly showed central pathological lesions in small blood vessel walls
of subcutaneous tissues and tremendous inﬂammatory cell inﬁltration
(Fig. 4b), linking EV71 infection to tissues of blood vessels (Fig. 2). On
the contrary, there were no clear histopathological lesions in blood
vessel endothelia of great blood vessels where high viral loads were
detected (Fig. 2), which might be explained by difﬁculties in
generating local inﬂammatory cell aggregation due to rapid blood
ﬂow in great vessels. In subcutaneous small blood vessels with a slow
blood ﬂow, virus might induce infection of endothelia upon attaching
to blood vessel walls, and this perhaps leads to local inﬂammatory cell
aggregation in response to various released inﬂammatory factors
(Compton et al., 2003). Despite the advances presented, further worky route.
7 8 9 10 11 12 13 14
+ +++ +++ ++ + ± − − −
+ ++++ ++++ +++ + − − − −
+++ ++++ +++ +++ ++ +++ ++ +++
+ ++++ ++ ++ − − − − −
++++ +++ ++ + − − − −
++++ +++ +++ ++ +++ ++ ++ ++
+++: copies≥104.
rocedure as described in manufacturer's protocol.
Table 2c
Pathological changes in CNS and respiratory tissues of new neonatal rhesus monkeys infected via respiratory route.
Pattern Monkey
ID
Pathological changes in different organs (days post infection)
CNSa Respiratory tissuesb
Cerebra Thalamus Midbrain Medulla oblongata Pons Cervical Thorax Lumbar Lung Trachea Bronchus
Infected new neonatal 5420 1 2 2 3 3 2 2 1 1 – –
5421 2 3 1 1 2 1 1 1 2E 1 1
Samples were collected on day 14 post-infected.
a CNS lesions were scored according to the evaluation of extent of pathological change in CNS: 0, no lesion; 1, cellular inﬁltration; 2, cellular inﬁltration with minimal neural
damage; 3, cellular inﬁltration with extensive neural damage; and 4, massive neural damage with or without cellular inﬁltration.
b Note: E: edema and/or hemorrhage. 1: cellular inﬁltration; 2: cellular inﬁltration and damage of tissue; 3: massive cellular inﬁltration and severe damage of tissue; –: no obvious
pathological change.
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ical mechanisms of these lesions in skin, but it should be noted that
the characterized clinical manifestations in EV71-infected neonatal
monkeys directly contribute to clear experimental signiﬁcance. Unlike
studies in murine and cynomolgus monkey models in which other
clinical symptoms such as paralysis and ataxia are common (Nagata et
al., 2004; Wang et al., 2004), no deﬁnite neurological complications
were noticed in the current study, except for a decrease in muscle
tension of limbs that is difﬁcult to quantify. Although EV71 strains
used in those studies are adapted for murine and cynomolgus
monkeys (Arita et al., 2005; Wang et al., 2004), there are differences
exhibited in terms of molecular biological events when compared to
the virus strain used in this rhesus monkey studies and that in human
infection, and further investigation into the related mechanisms and
the differences between the studies are required. However, one
remarkable point that deserves to be mentioned is that the ﬂaccid
paralysis observed in murine and cynomolgus monkey studies is not a
dominant manifestation in the population with HFMD reported
recently (Kung et al., 2007), despite of some paralysis cases that had
been reported in previous epidemics induced by B or C1 genotype
virus in Europe (Kapusinszky et al., 2010; Ortner et al., 2009). In
addition, the limited clinical manifestations showed that death and
serious encephalomyelitis symptoms frequently displayed in human
severe cases were failed to ﬁnd in these neonatal monkeys, which
leads us to raise the question of the variety of EV71 infection in rhesus
monkey and human. However, all the data presented in current study
are most likely to suggest a complete infectious process induced by
EV71 in neonatal monkeys. These clinical symptoms and pathological
ﬁndings, speciﬁcally in CNS presented in our work seem to allow for
two presumptions: ﬁrst, rhesus monkey might not be the natural host
for EV71 infection and not as sensitive as human for virus infection;
second, the 0.5% severe case reported in human by EV71 infection
could not be simply deﬁned in 8 neonatal monkeys in our experiment.
Our previous study in adult rhesus monkeys revealed a preference
of EV71 infection to respiratory tract tissues (Supplemental Table 1)
(Zhang et al., Submission) that is again conﬁrmed in the current study
of neonatal rhesus monkeys. The preference of EV71 infection to the
respiratory tract in neonates was detected using viral loads and
pathological changes in trachea tissues; other, higher viral loads were
found in tissues of axillary lymph nodes, cervical lymph nodes,
axillary and peritrachea brown adipose, upper arm muscle and
pectoralis muscle. These higher viral loads were thought to be
generated after initial infection by transmission of virus from the
trachea to adjacent lymph nodes and other tissues (Fig. 2), which
directly leads to viral transmission from involved peripheral nerves to
the CNS. Therefore, the respiratory tract is presumed to be a potential
natural infection route for EV71 in this model, which is further
supported by lower viral loads detected in gastrointestinal tract and
failure in noting remarkable pathological changes in other associated
organs like the gaster and the small intestine. As evidenced in viral
load analysis of the blood and EV71 antigen expressed in tissue
samples from the trachea, spleen, lymph nodes and etc. (Supplemen-tal Fig. 3), EV71 is presumed to enter into tissues of trachea and organs
of associated respiratory tracts, thereafter to overall spread and
transmit through the whole body. Viral load analysis revealed higher
viral loads in brown adipose tissue (Fig. 2), which appears to suggest
that brown adipose, a tissue primarily found in young humans and
other primates, should also be the primary target tissue for viral
replication. If this is the case, high infectious rates of EV71 in infants
and young children (McMinn, 2002) seem explainable. Higher viral
loads occur in tissues of blood vessels and skeletal muscles
highlighting the capability of EV71 to infect many tissue types,
which might correlate to a distribution of EV71 receptors in different
tissues (Wong et al., 2010).
As shown in both pathological analysis in humans and studies in
animal models, including rhesus monkeys in the presented work, the
CNS has widely been identiﬁed as the main target organ for EV71
infection. Study in murine models proposed the potential mechanism
of EV7 transmission from peripheral nerves to CNS via active
retrograde axonal transport route (Chen et al., 2007). In our current
work, higher viral loads were detected in brown adipose from day 4 p.
i. followed by peaks occurred in blood vessels, upper arm and lower
arm muscles and pectoralis muscles on day 7 p.i.. In parallel, viral
loads in tissues of peripheral nerves like brachial plexus and
intercostal nerves were increased dramatically (Fig. 3b), while viral
load in the CNS exhibited a slight increase (Fig. 3a). On day 10 p.i.
when viral loads in tissues of peripheral nerves, lymph nodes and
brown adipose tissue declined (Fig. 2), the viral loads in a wide range
of CNS samples, including every part of spinal cord, increased (Fig. 3)
and displayed severe neuropathological lesions as indicated in
histopathological examinations (Table 1). These ﬁndings allow for
an argument that EV71 achieves its target of infecting the CNS in
infected neonatal monkeys via a route of muscle tissue to peripheral
nerves and ﬁnally reaching tissues in the CNS. Interestingly, regardless
of papule or vesicle presence on the mouth, no virus was found in
trigeminal nerves; regardless of the presence of very low viral titers in
muscles of low limbs, no virus was detected in sciatic nerves. Taken
these results together, it might be safe to conclude that EV71 would
eventually infect a broad range of tissues in the CNS via peripheral
nerves by active retrograde axonal transport route based upon its
preference to respiratory tract infection and brown adipose tissues
adjacent to upper limbs as primary target tissues.
To evaluate the reliability of using neonatal monkeys as the animal
model, the feces taken from the EV71-infected monkeys, treated by
sterilization and ﬁltration, was used in infecting new neonatal
monkeys via the respiratory tract, and clearly resulted in a complete
infectious process consisting of the same steps and indicators in newly
infected individuals. These results have enabled us to basically
evaluate the reliability of this model in compliance with Koch's
postulates and lead to the ﬁnal conﬁrmation. However, based upon
the fact that some enteroviruses, especially poliovirus are capable of
inducing neuropathological changes in CNS of rhesus monkeys upon
infection that is similar to that indicated in our current work, it
appears to be necessary to further specify rhesus monkey models for
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showed negative results of Coxackievirus A16 infection in rhesus
monkey (data not shown), the study of generic susceptibility might be
required to further explore the neuropathological changes induced by
other enterovirus A of human species in neonatal rhesus monkey.
In summary, our current study and previous work highlight the
use of neonatal rhesus monkey as an animal model for EV71 infection
that can be applied to provide objective indicators for observation and
evaluation in interpreting the complete process of EV71 infection,
shedding light on mechanisms of EV71 infection and development of
new drugs and vaccines. Our work provides a valuable and signiﬁcant
basis for further study of the pathogenesis of EV71 in human patients
with HFMD. Although the data describing EV71 transmission in
humans and the associated mechanisms of pathogenesis are not fully
elucidated, the fact that the systemic infectious process, infection of
new hosts using fecal matter from infected hosts, and other collected
indicators in a neonatalmonkeymodel could repeatedly be duplicated
to contribute to the reliability of this model.
Materials and methods
Viruses and cells
The EV71 virus used in this study was strain FY-23 that was
isolated from a hematic secretion of the respiratory tract of an infected
male child who presented with the clinical symptoms of severe
cardiopulmonary collapse during an epidemic in Fuyang, China inMay
2008 (Genbank accession number: EU812515.1) (Ma et al., 2009). The
strain was puriﬁed using a 0.2-μm ﬁlter and identiﬁed as an EV71 C4
sub-genotype virus by RT-PCR before Vero cell inoculation. The virus
grown in Vero cells was harvested for freezing at −20 °C when a
typical cytopathic effect developed and the produced virus reached a
concentration of 106.5–107.5 cell culture infectious doses (CCID50)/ml.
The Vero cells were maintained in 0.5% MEM containing fetal bovine
serum and grown to a conﬂuent monolayer in a T-25 vessel or in 96-
well plates for viral isolation and neutralizing antibody assays.
Virus titration and neutralization assay
EV71 harvested from cell culture or isolates from different organs
and tissues of infected newborn rhesus monkeys were analyzed by
performing a microtitration assay using a standard protocol (Arita et
al., 2006). The neutralization test for the virus was performed
according to the standard protocol (WHO, 1988); a mixture of diluted
serum containing anti-EV71 antibodies and the virus at a titer of 500–
1000 CCID50 in 100 μl of phosphate-buffered saline (PBS) was
incubated at 37 °C for 1 h. The cellular pathogenic effect (CPE) of
the viruses was examined by inoculating the mixture onto Vero cells
grown in 96-well plates. The plaque assay was performed in 6-well
plates containing 90% conﬂuent Vero monolayer cells. The cells were
inoculated with samples from blood, throat swabs or feces. After 1 h
incubation at 37 °C, the infection media were aspirated off and each
well was then covered with 3 ml of agar overlay medium and
incubated for 2 days at 37 °C in a CO2 incubator. At the end of the
incubation, the cells were ﬁxed with formaldehyde and stained with
0.1% Crystal Violet as standard protocol (Hung et al., 2010).
Neonatal rhesus monkeys
The Ofﬁce of Laboratory Animal Management of Yunnan Province,
China approved the experimental animal procedure. A total of 14
healthy newborn rhesus monkeys with an average weight of 300
±350 g and an average age of 1–1.5 months were divided into two
experimental groups, eight for the ﬁrst group and four for the second
group; two additional monkeys were used as negative controls. Each
newborn monkey was kept in a single cage with its mother and fedaccording to the guidelines of the Committee of Experimental Animals
at the Institute of Medical Biology, Chinese Academy of Medical
Sciences (CAMS) (Gorska, 2000). All animals were kept in isolation for
2 weeks before the initiation of the study. A neutralization test was
conducted to conﬁrm that they did not have antibodies against EV71
prior to the experimental infections.
Infection in neonatal rhesus monkeys
The ﬁrst experimental group of 8 monkeys was challenged with
EV71 (104.5 CCID50/monkey) via the respiratory tract by tracheoscopy
according to standard protocol, in which the monkeys anesthetized
with ketamine (10 mg/kg of body weight, Phoenix Pharmaceuticals,
St. Joseph, Mo.) were infected by the 0.5 ml sterile saline consisting of
viruses in a manner of instilling into the desired trachea via the biopsy
channel of the bronchoscope. The 2 monkeys were used as uninfected
negative controls. The infected neonates were breast-fed by female
monkeys and monitored daily for clinical signs under un-anesthesia
twice a day, such as body temperature measured by inserting a soft
probe attached to Omron's electronic digital stick thermometers (MC-
BOMR, Omron Co.) into rectal 2 cm from anal margin for 1 min each
time, muscle tension of limbs, primary healthy status, papules or
vesicles on limbs, etc. from day 2 post-infection (p.i.). The normal
range of body temperature was deﬁned based upon the reference (Li
et al., 2005) and that of control animals. In parallel, venous blood
samples were taken into EDTA coated capillary tubes daily for routine
detection for biological indicators like blood count by Veterinary
Multi-species Hematology System (Hemavet 950FS, Drew Scientiﬁc
Co.), as well as viral loads. The normal percentage ranges of various
blood cells were deﬁned based upon the reference (Sibley et al.,
1974). The pathogenic and histopathological examinations were
performed on all the tissues and organs of neonates killed by electric
shock on days 4, 7, 10, and 14 p.i. with anesthesia.
Histopathological examination and immunohistochemical analysis
Various tissue samples from the organs of the infected monkeys
were ﬁxed in 10% formalin in PBS, dehydrated in ethanol gradients and
embedded in parafﬁn before obtaining 4-μm sections for further H–E
staining. Histopathological analysis of the tissue sections from each
organ was performed under a light microscope. Histological changes in
theCNS (lesion score)were evaluatedusing amethod recommendedby
the World Health Organization (WHO) (WHO, 1990), which included
standard pathological evaluations of the cerebrum, cerebellum, brain
stem and different sections of the spinal cord (Nagata et al., 2002). For
the immunohistochemical analysis, the tissue samples were embedded
in an optimal cutting temperature (OCT) compound (Miles Inc., Elkhart,
Ind.) and frozen in liquid nitrogen. The frozen tissueswere then cut into
4-μm sections, placed on poly-L-lysine-coated glass slides and ﬁxed in
3.7% paraformaldehyde. The endogenous peroxidase activity of the
tissues was inhibited by treatment with hydrogen peroxide (2.5%). The
EV71 antigen was detected by mouse anti-enterovirus 71 monoclonal
Antibody (Clone 10F0, Abcam, U.S.) and horseradish peroxidase (HRP)-
conjugated anti-mouse IgG antibodies (Sigma, Deisenhofen, Germany)
followedbycolor developmentwithdiaminobenzidine for thedetection
of the antigen–antibody reaction.
Extract of viral RNA and quantitative RT-PCR ampliﬁcation
Viral RNA was extracted from 250 μl of fresh tissue homogenate
(10%) and fecal homogenate (5%) from the experimental animals
using the Qiagen RNeasy mini kit, according to the manufacturer's
protocol (Qiagen, Hilden, Germany). The viral RNA was eluted in a
ﬁnal volume of 20 μl. For quantiﬁcation, a single-tube, real-time
Taqman RT-PCR assay was performed using the Taqman 1-step RT-
PCR Master Mix in the 7500 Fast Real-time RT-PCR system (Applied
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the Taqman Universal PCR master mix, each primer at 200 nM, the
FAM/TAMRA labeled probe at 100 nM (Takara Shuzo Co., Ltd., Shiga,
Japan), and 2 μl of RNA in a 20-μl total reaction volume. The se-
quences for the EV71-speciﬁc primers are as follows: forward primer,
5′-ccctgaatgcggctaatcc-3′; probe, 5′-ccagcgggtagtgtgtcgtaacggg-3′;
and reverse primer, 5′-attgtcaccataagcagcca-3′. The following proto-
col was used for all PCR assays: 5 min at 42 °C and 10 s at 95 °C,
followed by 40 cycles at 95 °C for 5 s and 60 °C for 30 s. A standard
reference curve was obtained by measurement of the serially diluted
virus RNA generated by in vitro transcription from a DNA construct
that contains the 5′-untranslated region (UTR). Based on the copy
number of standard RNA, we then quantiﬁed the viral titer relative to
the standard RNA by real-time RT-PCR analysis. Using this system, we
measured each viral load separately in the infected tissue. All results
were further conﬁrmed in microtitration assay with tissue culture.
Infection of new individual monkeys by feces of EV71-infected neonatal
monkeys
100 mg of feces of EV71-infected neonates at day 10 p.i. were
acquired and suspended in 5 ml PBS for sterilization and ﬁltration by a
0.2-μm ﬁlter. Each 500-μl solution was nasally inoculated into 4
negative neonates, conﬁrmed by anti-EV71 antibody detection, and 2
to 2.5-month-old neonates. The infected neonates were monitored
daily for the aforementioned clinical signs from day 2 until day 14 p.i.
when two of the monkeys challenged via respiratory route were
killed, and the other two were kept for daily virus detection in feces
until day 30 p.i. In parallel, fecal samples from the breast-feeding
monkeys for these 2 neonates were taken for daily virus detection
from days 14 to 30 p.i.
Electron microscopy analysis
The tissue was prepared and ﬁxed in a solution containing 0.5%
glutaraldehyde, 4% paraformaldehyde, and 0.1 M of sodium phos-
phate buffer (pH 7.6) on ice for 1 h. After washes with 4% sucrose in
0.1 M of phosphate buffer, the tissue was decalciﬁed with 2.5% EDTA
solution for 5 days. After three washes, the samples were ﬁxed with
2% osmium tetraoxide on ice for 1 h and dehydrated with a series of
ethanol gradients. For transmission electron microscopy, the tissues
were embedded in Epon 812 resin mixture, and ultrathin (70-nm)
sections were cut with Leica EM UC6 ultramicrotome (Leica Co.,
Austria). The ultrathin sections were stained with 2% uranyl acetate in
70% ethanol for 5 min at room temperature and then in Reynold's lead
for 5 min at room temperature. Sections were analyzed with H-7650
transmission electron microscope (HITACHI, Japan).
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2010.12.058.
Acknowledgments
This work was supported by National S&T Major Project
(2008ZX10004-014) and National Basic Research Program
(2011CB504903).
References
Arita, M., Shimizu, H., Nagata, N., Ami, Y., Suzaki, Y., Sata, T., Iwasaki, T., Miyamura, T.,
2005. Temperature-sensitive mutants of enterovirus 71 show attenuation in
cynomolgus monkeys. J. Gen. Virol. 86 (Pt 5), 1391–1401.
Arita, M., Nagata, N., Sata, T., Miyamura, T., Shimizu, H., 2006. Quantitative analysis of
poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J. Gen. Virol.
87 (Pt 11), 3317–3327.
Arita, M., Nagata, N., Iwata, N., Ami, Y., Suzaki, Y., Mizuta, K., Iwasaki, T., Sata, T., Wakita,
T., Shimizu, H., 2007. An attenuated strain of enterovirus 71 belonging to genotype
a showed a broad spectrum of antigenicity with attenuated neurovirulence in
cynomolgus monkeys. J. Virol. 81 (17), 9386–9395.Asher, L.V., Binn, L.N., Mensing, T.L., Marchwicki, R.H., Vassell, R.A., Young, G.D., 1995.
Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus). J.
Med. Virol. 47 (3), 260–268.
Bodian, D., 1955. Emerging concept of poliomyelitis infection. Science 122 (3159),
105–108.
CDC, 1998. Deaths among children during an outbreak of hand, foot, and mouth
disease— Taiwan, Republic of China, April–July 1998. MMWRMorb. Mortal. Wkly
Rep. 47, 629–632.
Chan, L.G., Parashar, U.D., Lye, M.S., Ong, F.G., Zaki, S.R., Alexander, J.P., Ho, K.K., Han, L.L.,
Pallansch, M.A., Suleiman, A.B., Jegathesan, M., Anderson, L.J., 2000. Deaths of
children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia:
clinical and pathological characteristics of the disease. For the Outbreak Study
Group. Clin. Infect. Dis. 31 (3), 678–683.
Chen, Y.C., Yu, C.K., Wang, Y.F., Liu, C.C., Su, I.J., Lei, H.Y., 2004. A murine oral enterovirus
71 infection model with central nervous system involvement. J. Gen. Virol. 85 (Pt
1), 69–77.
Chen, C.S., Yao, Y.C., Lin, S.C., Lee, Y.P., Wang, Y.F., Wang, J.R., Liu, C.C., Lei, H.Y., Yu, C.K.,
2007. Retrograde axonal transport: a major transmission route of enterovirus 71 in
mice. J. Virol. 81 (17), 8996–9003.
Compton, T., Kurt-Jones, E.A., Boehme, K.W., Belko, J., Latz, E., Golenbock, D.T., Finberg,
R.W., 2003. Human cytomegalovirus activates inﬂammatory cytokine responses via
CD14 and Toll-like receptor 2. J. Virol. 77 (8), 4588–4596.
Couderc, T., Christodoulou, C., Kopecka, H., Marsden, S., Taffs, L.F., Crainic, R., Horaud, F.,
1989. Molecular pathogenesis of neural lesions induced by poliovirus type 1. J. Gen.
Virol. 70 (Pt 11), 2907–2918.
Ding, N.Z., Wang, X.M., Sun, S.W., Song, Q., Li, S.N., He, C.Q., 2009. Appearance of mosaic
enterovirus 71 in the 2008 outbreak of China. Virus Res. 145 (1), 157–161.
Dragunsky, E., Taffs, R., Chernokhvostova, Y., Nomura, T., Hioki, K., Gardner, D.,
Norwood, L., Levenbook, I., 1996. A poliovirus-susceptible transgenic mouse model
as a possible replacement for the monkey neurovirulence test of oral poliovirus
vaccine. Biologicals 24 (2), 77–86.
Gorska, P., 2000. Principles in laboratory animal research for experimental purposes.
Med. Sci. Monit. 6 (1), 171–180.
Han, J., Ma, X.J., Wan, J.F., Liu, Y.H., Han, Y.L., Chen, C., Tian, C., Gao, C., Wang, M., Dong,
X.P., 2010. Long persistence of EV71 speciﬁc nucleotides in respiratory and feces
samples of the patients with Hand–Foot–Mouth Disease after recovery. BMC
Infect. Dis. 10, 178.
Hashimoto, I., Hagiwara, A., 1983. Comparative studies on the neurovirulence of
temperature-sensitive and temperature-resistant viruses of enterovirus 71 in
monkeys. Acta Neuropathol. 60 (3–4), 266–270.
Ho, M., Chen, E.R., Hsu, K.H., Twu, S.J., Chen, K.T., Tsai, S.F., Wang, J.R., Shih, S.R., 1999. An
epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic
Working Group. N. Engl. J. Med. 341 (13), 929–935.
Horie, H., Koike, S., Kurata, T., Sato-Yoshida, Y., Ise, I., Ota, Y., Abe, S., Hioki, K., Kato, H.,
Taya, C., et al., 1994. Transgenic mice carrying the human poliovirus receptor: new
animal models for study of poliovirus neurovirulence. J. Virol. 68 (2), 681–688.
Hsueh, C., Jung, S.M., Shih, S.R., Kuo, T.T., Shieh, W.J., Zaki, S., Lin, T.Y., Chang, L.Y., Ning,
H.C., Yen, D.C., 2000. Acute encephalomyelitis during an outbreak of enterovirus
type 71 infection in Taiwan: report of an autopsy case with pathologic,
immunoﬂuorescence, and molecular studies. Mod. Pathol. 13 (11), 1200–1205.
Hung, H.C., Chen, T.C., Fang, M.Y., Yen, K.J., Shih, S.R., Hsu, J.T., Tseng, C.P., 2010.
Inhibition of enterovirus 71 replication and the viral 3D polymerase by
aurintricarboxylic acid. J. Antimicrob. Chemother. 65 (4), 676–683.
Kapusinszky, B., Szomor, K.N., Farkas, A., Takacs, M., Berencsi, G., 2010. Detection of
non-polio enteroviruses in Hungary 2000–2008 and molecular epidemiology of
enterovirus 71, coxsackievirus A16, and echovirus 30. Virus Genes 40 (2), 163–173.
Kung, C.M., King, C.C., Lee, C.N., Huang, L.M., Lee, P.I., Kao, C.L., 2007. Differences in
replication capacity between enterovirus 71 isolates obtained from patients with
encephalitis and those obtained from patients with herpangina in Taiwan. J. Med.
Virol. 79 (1), 60–68.
Li, C.C., Yang, M.Y., Chen, R.F., Lin, T.Y., Tsao, K.C., Ning, H.C., Liu, H.C., Lin, S.F., Yeh, W.T.,
Chu, Y.T., Yang, K.D., 2002. Clinical manifestations and laboratory assessment in an
enterovirus 71 outbreak in southern Taiwan. Scand. J. Infect. Dis. 34 (2), 104–109.
Li, B.J., Tang, Q., Cheng, D., Qin, C., Xie, F.Y., Wei, Q., Xu, J., Liu, Y., Zheng, B.J., Woodle, M.C.,
Zhong, N., Lu, P.Y., 2005. Using siRNA in prophylactic and therapeutic regimens
against SARS coronavirus in Rhesus macaque. Nat. Med. 11 (9), 944–951.
Lin, T.Y., Hsia, S.H., Huang, Y.C., Wu, C.T., Chang, L.Y., 2003a. Proinﬂammatory cytokine
reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis.
36 (3), 269–274.
Lin, T.Y., Twu, S.J., Ho, M.S., Chang, L.Y., Lee, C.Y., 2003b. Enterovirus 71 outbreaks,
Taiwan: occurrence and recognition. Emerg. Infect. Dis. 9 (3), 291–293.
Lin, M.T., Wang, J.K., Lu, F.L., Wu, E.T., Yeh, S.J., Lee, W.L., Wu, J.M., Wu, M.H., 2006. Heart
rate variability monitoring in the detection of central nervous system
complications in children with enterovirus infection. J. Crit. Care 21 (3),
280–286.
Liu, C.C., Tseng, H.W., Wang, S.M., Wang, J.R., Su, I.J., 2000. An outbreak of enterovirus 71
infection in Taiwan, 1998: epidemiologic and clinical manifestations. J. Clin. Virol.
17 (1), 23–30.
Ma, S.-h., Liu, J.-s., Wang, J.-j., Shi, H.-j., Yang, H.-j., Chen, J.-y., Liu, L.-d., Li, Q.-h., 2009.
Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in
Fuyang, China, during 2008. Virol. Sin. 24 (3), 162–170.
McMinn, P.C., 2002. An overview of the evolution of enterovirus 71 and its clinical and
public health signiﬁcance. FEMS Microbiol. Rev. 26 (1), 91–107.
Mena, I., Fischer, C., Gebhard, J.R., Perry, C.M., Harkins, S., Whitton, J.L., 2000.
Coxsackievirus infection of the pancreas: evaluation of receptor expression,
pathogenesis, and immunopathology. Virology 271 (2), 276–288.
100 L. Liu et al. / Virology 412 (2011) 91–100Nagata, N., Shimizu, H., Ami, Y., Tano, Y., Harashima, A., Suzaki, Y., Sato, Y., Miyamura, T.,
Sata, T., Iwasaki, T., 2002. Pyramidal and extrapyramidal involvement in
experimental infection of cynomolgus monkeys with enterovirus 71. J. Med.
Virol. 67 (2), 207–216.
Nagata, N., Iwasaki, T., Ami, Y., Tano, Y., Harashima, A., Suzaki, Y., Sato, Y., Hasegawa, H.,
Sata, T., Miyamura, T., Shimizu, H., 2004. Differential localization of neurons
susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of
cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 85 (Pt 10),
2981–2989.
Ong, K.C., Badmanathan, M., Devi, S., Leong, K.L., Cardosa, M.J., Wong, K.T., 2008.
Pathologic characterization of a murine model of human enterovirus 71
encephalomyelitis. J. Neuropathol. Exp. Neurol. 67 (6), 532–542.
Ooi, M.H., Solomon, T., Podin, Y., Mohan, A., Akin, W., Yusuf, M.A., del Sel, S., Kontol, K.M.,
Lai, B.F., Clear, D., Chieng, C.H., Blake, E., Perera, D., Wong, S.C., Cardosa, J., 2007.
Evaluation of different clinical sample types in diagnosis of human enterovirus 71-
associated hand–foot-and-mouth disease. J. Clin. Microbiol. 45 (6), 1858–1866.
Ortner, B., Huang, C.W., Schmid, D., Mutz, I., Wewalka, G., Allerberger, F., Yang, J.Y.,
Huemer, H.P., 2009. Epidemiology of enterovirus types causing neurological
disease in Austria 1999–2007: detection of clusters of echovirus 30 and enterovirus
71 and analysis of prevalent genotypes. J. Med. Virol. 81 (2), 317–324.
Ouzilou, L., Caliot, E., Pelletier, I., Prevost, M.C., Pringault, E., Colbere-Garapin, F., 2002.
Poliovirus transcytosis through M-like cells. J. Gen. Virol. 83 (Pt 9), 2177–2182.
Racaniello, V.R., 2006. One hundred years of poliovirus pathogenesis. Virology 344 (1),
9–16.
Shimizu, H., Utama, A., Yoshii, K., Yoshida, H., Yoneyama, T., Sinniah, M., Yusof, M.A.,
Okuno, Y., Okabe, N., Shih, S.R., Chen, H.Y., Wang, G.R., Kao, C.L., Chang, K.S.,
Miyamura, T., Hagiwara, A., 1999. Enterovirus 71 from fatal and nonfatal cases of
hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997–
1998. Jpn J. Infect. Dis. 52 (1), 12–15.Shwartzman, G., Aronson, S.M., Teodoru, C.V., Adler, M., Jahiel, R., 1955. Endocrinolog-
ical aspects of pathogenesis of experimental poliomyelitis. Ann. NY Acad. Sci. 61
(4), 869–876.
Sibley, P.L., Traina, V.M., Parekh, C.K., 1974. Normal range and variability of hematologic
and blood-chemical parameters from beagle dogs and rhesus monkeys. Toxicol.
Pathol. 2, 22–28.
Wang, Y.F., Chou, C.T., Lei, H.Y., Liu, C.C., Wang, S.M., Yan, J.J., Su, I.J., Wang, J.R., Yeh, T.M.,
Chen, S.H., Yu, C.K., 2004. A mouse-adapted enterovirus 71 strain causes
neurological disease in mice after oral infection. J. Virol. 78 (15), 7916–7924.
Whitton, J.L., Cornell, C.T., Feuer, R., 2005. Host and virus determinants of picornavirus
pathogenesis and tropism. Nat. Rev. Microbiol. 3 (10), 765–776.
WHO, 1988. Procedure for Using the Lyophilized LBM Pools for Typing Enterovirus,
Geneva.
WHO, 1990. Requirements for poliomyelitis vaccine (oral). WHO Tech. Rep. Ser. 800,
30–65.
Wong, K.T., Munisamy, B., Ong, K.C., Kojima, H., Noriyo, N., Chua, K.B., Ong, B.B.,
Nagashima, K., 2008. The distribution of inﬂammation and virus in human
enterovirus 71 encephalomyelitis suggests possible viral spread by neural path-
ways. J. Neuropathol. Exp. Neurol. 67 (2), 162–169.
Wong, S.S., Yip, C.C., Lau, S.K., Yuen, K.Y., 2010. Human enterovirus 71 and hand, foot
and mouth disease. Epidemiol. Infect. 138 (8), 1071–1089.
Xu, J., Qian, Y., Wang, S., Serrano, J.M., Li, W., Huang, Z., Lu, S., 2010. EV71: an emerging
infectious disease vaccine target in the Far East? Vaccine 28 (20), 3516–3521.
Yang, F., Ren, L., Xiong, Z., Li, J., Xiao, Y., Zhao, R., He, Y., Bu, G., Zhou, S., Wang, J., Qi, J.,
2009. Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin.
Microbiol. 47 (7), 2351–2352.
Zhang, Y., Cui, W., Liu, L., Wang, J., Zhao, H., Liao, Y., Na, R., Dong, C., Wang, L., Xie, Z., Gao,
J., Cui, P., Zhang, X., and Li, Q. (Submission). Pathogenesis study of enterovirus 71
infection in rhesus monkeys. Submission.
